Literature DB >> 28774193

Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.

Roman Kotov1, Laura Fochtmann1, Kaiqiao Li1, Marsha Tanenberg-Karant1, Eduardo A Constantino1, Joan Rubinstein1, Greg Perlman1, Eva Velthorst1, Anne-Kathrin J Fett1, Gabrielle Carlson1, Evelyn J Bromet1.   

Abstract

OBJECTIVE: Kraepelin considered declining course a hallmark of schizophrenia, but others have suggested that outcomes usually stabilize or improve after treatment initiation. The authors investigated this question in an epidemiologically defined cohort with psychotic disorders followed for 20 years after first hospitalization.
METHOD: The Suffolk County Mental Health Project recruited first-admission patients with psychosis from all inpatient units of Suffolk County, New York (response rate, 72%). Participants were assessed in person six times over two decades; 373 completed the 20-year follow-up (68% of survivors); 175 had schizophrenia/schizoaffective disorder. Global Assessment of Functioning (GAF), psychotic symptoms, and mood symptoms were rated at each assessment. Month 6, when nearly all participants were discharged from the index hospitalization, was used as a reference.
RESULTS: In the schizophrenia group, mean GAF scores declined from 49 at month 6 to 36 at year 20. Negative and positive symptoms also worsened (Cohen's d values, 0.45-0.73). Among participants without schizophrenia, GAF scores were higher initially (a mean of approximately 64) but declined by 9 points over the follow-up period. Worsening began between years 5 and 8. Neither aging nor changes in antipsychotic treatment accounted for the declines. In all disorders, depression improved and manic symptoms remained low across the 20 years.
CONCLUSIONS: The authors found substantial symptom burden across disorders that increased with time and ultimately may undo initial treatment gains. Previous studies have suggested that better health care delivery models may preempt this decline. In the United States, these care needs are often not met, and addressing them is an urgent priority.

Entities:  

Keywords:  Bipolar Disorder Longitudinal; Epidemiology; First Episode; Outcome Studies; Psychosis

Mesh:

Year:  2017        PMID: 28774193      PMCID: PMC5767161          DOI: 10.1176/appi.ajp.2017.16101191

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  34 in total

1.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.

Authors:  A Jablensky; N Sartorius; G Ernberg; M Anker; A Korten; J E Cooper; R Day; A Bertelsen
Journal:  Psychol Med Monogr Suppl       Date:  1992

Review 2.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

3.  Estimating regression models with unknown break-points.

Authors:  Vito M R Muggeo
Journal:  Stat Med       Date:  2003-10-15       Impact factor: 2.373

Review 4.  Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?

Authors:  Martin Harrow; Thomas H Jobe
Journal:  Schizophr Bull       Date:  2013-03-19       Impact factor: 9.306

5.  Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.

Authors:  Lex Wunderink; Roeline M Nieboer; Durk Wiersma; Sjoerd Sytema; Fokko J Nienhuis
Journal:  JAMA Psychiatry       Date:  2013-09       Impact factor: 21.596

6.  Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort.

Authors:  Stephen F Austin; Ole Mors; Esben Budtz-Jørgensen; Rikke Gry Secher; Carsten R Hjorthøj; Mette Bertelsen; Pia Jeppesen; Lone Petersen; Anne Thorup; Merete Nordentoft
Journal:  Schizophr Res       Date:  2015-08-08       Impact factor: 4.939

7.  Boundaries of schizoaffective disorder: revisiting Kraepelin.

Authors:  Roman Kotov; Shirley H Leong; Ramin Mojtabai; Ann C Eckardt Erlanger; Laura J Fochtmann; Eduardo Constantino; Gabrielle A Carlson; Evelyn J Bromet
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

8.  The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy.

Authors:  P F Liddle
Journal:  Br J Psychiatry       Date:  1987-08       Impact factor: 9.319

9.  Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study.

Authors:  C Morgan; J Lappin; M Heslin; K Donoghue; B Lomas; U Reininghaus; A Onyejiaka; T Croudace; P B Jones; R M Murray; P Fearon; G A Doody; P Dazzan
Journal:  Psychol Med       Date:  2014-02-26       Impact factor: 7.723

10.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

View more
  21 in total

1.  What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Authors:  Christoph U Correll; Jose M Rubio; John M Kane
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

2.  Long-term antipsychotic treatment of schizophrenia: does it help or hurt over a 20-year period?

Authors:  Martin Harrow; Thomas H Jobe
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

3.  Physical Functional Limitations in a First-Admission Cohort at Midlife: Findings From the Suffolk County Mental Health Project.

Authors:  Sean A P Clouston; Katherine Jonas; Laura J Fochtmann; Evelyn J Bromet; Roman Kotov
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

4.  Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.

Authors:  Margo W Menkes; Kristan Armstrong; Jennifer Urbano Blackford; Stephan Heckers; Neil D Woodward
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

5.  Common Taxonomy of Traits and Symptoms: Linking Schizophrenia Symptoms, Schizotypy, and Normal Personality.

Authors:  David C Cicero; Katherine G Jonas; Kaiqiao Li; Greg Perlman; Roman Kotov
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

6.  Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.

Authors:  Emma E M Knowles; Samuel R Mathias; Godfrey D Pearlson; Jennifer Barrett; Josephine Mollon; Dominique Denbow; Katrina Aberzik; Molly Zatony; David C Glahn
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

7.  Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum.

Authors:  Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

8.  Relational Memory in the Early Stage of Psychosis: A 2-Year Follow-up Study.

Authors:  Suzanne N Avery; Kristan Armstrong; Maureen McHugo; Simon Vandekar; Jennifer Urbano Blackford; Neil D Woodward; Stephan Heckers
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

9.  Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders: Findings From the Suffolk County Mental Health Project.

Authors:  Anne-Kathrin J Fett; Eva Velthorst; Abraham Reichenberg; Camilo J Ruggero; Jennifer L Callahan; Laura J Fochtmann; Gabrielle A Carlson; Greg Perlman; Evelyn J Bromet; Roman Kotov
Journal:  JAMA Psychiatry       Date:  2020-04-01       Impact factor: 21.596

10.  Associations of independent living and labor force participation with impairment indicators in schizophrenia and bipolar disorder at 20-year follow-up.

Authors:  M Strassnig; R Kotov; L Fochtmann; M Kalin; E J Bromet; P D Harvey
Journal:  Schizophr Res       Date:  2018-02-19       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.